Clinical and reimbursement issues in growth hormone use in adults

American Journal of Managed Care

Volumn 6, Issue 15 SUPPL., 2000, Pages

  Biller, B M K ^a   Vance, M L ^a   Kleinberg, D L ^a   Cook, D M ^a   Gordon, T ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GROWTH HORMONE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SOMATOMEDIN;

ADULT; AGING; BODY COMPOSITION; BONE DENSITY; CARDIOMYOPATHY; CATABOLISM; CONFERENCE PAPER; FOLLOW UP; GROWTH HORMONE DEFICIENCY; HEART FUNCTION; HORMONE SUBSTITUTION; HUMAN; HYPOPHYSIS DISEASE; HYPOTHALAMUS DISEASE; LIPID BLOOD LEVEL; MANAGED CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REIMBURSEMENT; WASTING SYNDROME;

ADULT; CASE REPORT; GROWTH DISORDERS; GROWTH HORMONE; HORMONE REPLACEMENT THERAPY; HUMAN; INSURANCE COVERAGE; MANAGED CARE PROGRAMS;

EID: 0033818901     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (9)

1. Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: Summary statement of the Growth Hormone Research Society Workshop in Adult Growth Hormone Deficiency
2. Premature mortality due to cardiovascular disease in hypopituitarism
3. The effect of hypopituitarism on life expectancy
4. Increased cerebrovascular mortality in patients with hypopituitarism
5. Adult growth hormone deficiencies
6. Adult growth hormone (GH) deficient patients demonstrate heterogeneity between childhood onset before and during human GH treatment
7. Nitric oxide may mediate the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency. A double-blind placebo-controlled study
8. Hypopituitary females have a high incidence of cardiovascular mortality and an increased prevalence of cardiovascular risk factors
9. Effects of physiologic growth hormone therapy on bone mineral density and body composition in patients with adult-onset growth hormone deficiency